Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-03-18
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 200
- Registration Number
- NCT00195026
- Locations
- 🇺🇸
Weill Cornell Breast Center, New York, New York, United States
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
Phase 1
Terminated
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2007-07-20
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 29
- Registration Number
- NCT00195078
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Weekly Topotecan Therapy in Patients With Ovarian Cancer
Phase 2
Terminated
- Conditions
- Ovarian Cancer
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-09-13
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 32
- Registration Number
- NCT00194935
- Locations
- 🇺🇸
Weill Medcial College of Cornell University, New York, New York, United States
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
Phase 1
Terminated
- Conditions
- Solid Tumor Malignancies
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-09-14
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00195156
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Psychosocial Determinants of Medication Adherence in Hypertensive African Americans
- Conditions
- Hypertension
- Interventions
- Behavioral: Self affirmation and positive affect induction vs. control
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-05-21
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 262
- Registration Number
- NCT00195182
- Locations
- 🇺🇸
New York Presbyterian Hospital-Weill Medical College, New York, New York, United States
Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome (IBS)
- Interventions
- Dietary Supplement: E. Coli Strain M17 Probiotic
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-04-04
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 35
- Registration Number
- NCT00194922
- Locations
- 🇺🇸
Cornell Weill Medical College, New York City, New York, United States
Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study
Completed
- Conditions
- Asthma
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 60
- Registration Number
- NCT00195065
- Locations
- 🇺🇸
New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, United States
Prognostic Measures in Ambulatory Care Settings
Completed
- Conditions
- General Internal Medicine Patients
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-03-28
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2000
- Registration Number
- NCT00195130
- Locations
- 🇺🇸
New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, United States
An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus)
Phase 4
Completed
- Conditions
- Diabetic Neuropathy
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-03-25
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 8
- Registration Number
- NCT00194909
- Locations
- 🇺🇸
Peripheral Neuropathy Center - Weill Cornell Medical College, New York, New York, United States
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
Phase 4
Terminated
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2008-03-25
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 15
- Registration Number
- NCT00194961
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath